American Society of Clinical Oncology (ASCO)

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma
American Society of Clinical Oncology (ASCO) - Tập 27 Số 4 - Trang 612-618 - 2009
Eiji Kikuchi, Vitaly Margulis, Pierre I. Karakiewicz, Marco Roscigno, Shuji Mikami, Yair Lotan, Mesut Remzi, Christian Bolenz, Cord Langner, Alon Z. Weizer, Francesco Montorsi, Karim Bensalah, Theresa M. Koppie, Mario I. Fernández, Jay D. Raman, Wassim Kassouf, Christopher G. Wood, Nazareno Suardi, Mototsugu Oya, Shahrokh F. Shariat
Purpose To assess the association of lymphovascular invasion (LVI) with cancer recurrence and survival in a large international series of patients treated with radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC). Patients and Methods Data were collected on 1,45...... hiện toàn bộ
Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.
American Society of Clinical Oncology (ASCO) - Tập 8 Số 5 - Trang 892-898 - 1990
Joseph D. McCracken, Lalitha M. Janaki, John J. Crowley, S A Taylor, Padmini Giri, G B Weiss, William Gordon, Lawrence Baker, Anita Mansouri, J. Philip Kuebler
The Southwest Oncology Group (SWOG) has conducted a phase II study to explore the efficacy and toxicity of initial, concurrent use of radiation therapy with cisplatin, etoposide (VP-16), and vincristine in limited-stage small-cell carcinoma of the lung. Two courses of cisplatin, VP-16, and vincristine chemotherapy were given with concurrent radiotherapy (XRT) to the primary tumor to a tot...... hiện toàn bộ
Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants.
American Society of Clinical Oncology (ASCO) - Tập 4 Số 9 - Trang 1307-1313 - 1986
Kell Østerlind, Heine H. Hansen, Mogens Hansen, P Dombernowsky, Per Kragh Andersen
The influence of treatment and of pretreatment patient characteristics on the probability of long-term disease-free survival in small-cell lung cancer (SCLC) was investigated in a consecutive series of 874 patients. The patients were included in six controlled treatment trials from 1973 to 1981, using different combinations of chemotherapy with or without irradiation. All patients underwe...... hiện toàn bộ
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
American Society of Clinical Oncology (ASCO) - Tập 13 Số 5 - Trang 1215-1220 - 1995
Ulrik Lassen, Kell Østerlind, Mogens Hansen, P Dombernowsky, Bengt Bergman, Heine H. Hansen
PURPOSE To describe in patients with small-cell lung cancer (SCLC) the characteristics of those who survive for > or = 5 years, to identify long-term prognostic factors, to analyze survival data of 5-year survivors, and to study 10-year survival in patients entered before 1981. PATIENTS AND METHODS...... hiện toàn bộ
Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
American Society of Clinical Oncology (ASCO) - Tập 7 Số 3 - Trang 344-354 - 1989
Donna Spiegelman, L. Herbert Maurer, John Ware, Michael C. Perry, A. Philippe Chahinian, Robert L. Comis, Walter L. Eaton, Bonnie Zimmer, M Green
Cancer and Leukemia Group B (CALGB) accrued 1,745 patients with limited (LD) or extensive (ED) small-cell lung cancer (SCCL) to five separate trials between 1972 and 1986. We reviewed these data to evaluate the impact of pretreatment prognostic factors on outcome. In multivariate analysis, female gender was predictive of improved response (LD, P = .01; ED, P = .04) and survival (LD, P = ....... hiện toàn bộ
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.
American Society of Clinical Oncology (ASCO) - Tập 2 Số 4 - Trang 294-304 - 1984
Ronald Feld, William K. Evans, Gerrit DeBoer, Ian Quirt, Frances A. Shepherd, J L Yeoh, J Pringle, David G. Payne, James G. Herman, Donald H. Chamberlain
One hundred fifty-three patients with limited and 167 with extensive small cell carcinoma of the lung (SCCL) were evaluable for response to treatment with six courses of chemotherapy (cyclophosphamide, doxorubicin, and vincristine), irradiation to intrathoracic disease, and prophylactic cranial irradiation (PCI). No maintenance chemotherapy was given. Fifty-two percent of patients with li...... hiện toàn bộ
Small-cell carcinoma of the lung: derivation of a prognostic staging system.
American Society of Clinical Oncology (ASCO) - Tập 9 Số 9 - Trang 1639-1649 - 1991
U Sagman, Ellen Maki, William K. Evans, David Warr, Frances A. Shepherd, Jean‐Paul Sculier, Riad Haddad, David G. Payne, J Pringle, J L Yeoh
Retrospective data on 22 pretreatment attributes were evaluated in 614 patients with small-cell carcinoma of the lung (SCCL). The series included 284 patients with limited disease (LD) and 328 patients with extensive disease (ED) managed between 1974 and 1986. Prognostic factors were evaluated by univariate analysis and by the Cox multivariate regression model. Recursive partition and ama...... hiện toàn bộ
Long-term survival in small-cell carcinoma of the lung: a population experience.
American Society of Clinical Oncology (ASCO) - Tập 3 Số 1 - Trang 80-91 - 1985
Susan R. Davis, Peter Wright, Susan Schulman, Delia Scholes, David Thorning, Samuel P. Hammar
Small-cell lung carcinoma (SCLC) is a rapidly progressive and fatal disease. Historically, surgical resection or radiotherapy of the primary tumor has done little to prolong survival, although the use of combination chemotherapy is more effective. Reported here is the survival experience of 1,538 incident cases of SCLC identified through the Surveillance, Epidemiology and End Results Prog...... hiện toàn bộ
Treatment of small-cell lung cancer on protocol: potential bias of results.
American Society of Clinical Oncology (ASCO) - Tập 4 Số 9 - Trang 1314-1320 - 1986
Élisabeth Quoix, Harriet Schwartz Finkelstein, N Wolkove, Harvey Kreisman
During a 27-month period, 215 new cases of lung cancer were diagnosed at five McGill University hospitals. Only 44 patients (20%) so diagnosed were treated on available chemotherapy protocols. Six categories were used to define reasons for nonparticipation. The most important were medical reasons (MRs), 46%; non-medical reasons (NMRs), 20%; and physician preference (PP), 16%. The three re...... hiện toàn bộ
Depression in Patients With Lung Cancer: Prevalence and Risk Factors Derived From Quality-of-Life Data
American Society of Clinical Oncology (ASCO) - Tập 18 Số 4 - Trang 893-893 - 2000
Penelope Hopwood, Richard Stephens
PURPOSE: To evaluate self-reported depression rates in patients with inoperable lung cancer and to explore demographic, clinical, and quality-of-life (QOL) factors associated with depression and thus identify patients at risk. PATIENTS AND METHODS: Nine hundred eighty-seven patients from three palliative treatment trials conducted by the Medical Research Council Lung Can...... hiện toàn bộ
Tổng số: 1,453   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10